Section 51.0003 - Requirements; Notice(a) The program: (1) must collaborate with physicians and health care providers to notify a prospective subject about the program when: (A) the prospective subject provides informed consent for a cancer clinical trial; or(B) funding is available to provide the program for the cancer clinical trial in which the prospective subject participates;(2) must reimburse subjects based on financial need, which may include reimbursement to subjects whose income is at or below 700 percent of the federal poverty level;(3) must provide reimbursement for ancillary costs, including costs described by Section 51.0002, to eliminate the financial barriers to enrollment in a clinical trial;(4) may provide reimbursement for reasonable ancillary costs, including costs described by Section 51.0002, to one family member, friend, or other person who attends a cancer clinical trial to support a subject; and(5) must comply with applicable federal and state laws.(b) The independent, third-party organization administering the program shall provide written notice to prospective subjects of the requirements described by Subsection (a).Tex. Health and Safety Code § 51.0003
Amended by Acts 2021, Texas Acts of the 87th Leg. - Regular Session, ch. 915,Sec. 21.002, eff. 9/1/2021.Renumbered from Tex. Health and Safety Code § 50.0003 by Acts 2021, Texas Acts of the 87th Leg. - Regular Session, ch. 915,Sec. 21.001, eff. 9/1/2021.Added by Acts 2019, Texas Acts of the 86th Leg.- Regular Session, ch. 1157,Sec. 2, eff. 9/1/2019.